260 related articles for article (PubMed ID: 34751990)
1. Cation-Free siRNA Micelles as Effective Drug Delivery Platform and Potent RNAi Nanomedicines for Glioblastoma Therapy.
Jiang T; Qiao Y; Ruan W; Zhang D; Yang Q; Wang G; Chen Q; Zhu F; Yin J; Zou Y; Qian R; Zheng M; Shi B
Adv Mater; 2021 Nov; 33(45):e2104779. PubMed ID: 34751990
[TBL] [Abstract][Full Text] [Related]
2. Single siRNA Nanocapsules for Effective siRNA Brain Delivery and Glioblastoma Treatment.
Zou Y; Sun X; Wang Y; Yan C; Liu Y; Li J; Zhang D; Zheng M; Chung RS; Shi B
Adv Mater; 2020 Jun; 32(24):e2000416. PubMed ID: 32374446
[TBL] [Abstract][Full Text] [Related]
3. ROS-Responsive Polymeric siRNA Nanomedicine Stabilized by Triple Interactions for the Robust Glioblastoma Combinational RNAi Therapy.
Zheng M; Liu Y; Wang Y; Zhang D; Zou Y; Ruan W; Yin J; Tao W; Park JB; Shi B
Adv Mater; 2019 Sep; 31(37):e1903277. PubMed ID: 31348581
[TBL] [Abstract][Full Text] [Related]
4. Charge Conversional Biomimetic Nanocomplexes as a Multifunctional Platform for Boosting Orthotopic Glioblastoma RNAi Therapy.
Liu Y; Zou Y; Feng C; Lee A; Yin J; Chung R; Park JB; Rizos H; Tao W; Zheng M; Farokhzad OC; Shi B
Nano Lett; 2020 Mar; 20(3):1637-1646. PubMed ID: 32013452
[TBL] [Abstract][Full Text] [Related]
5. Codelivery of temozolomide and siRNA with polymeric nanocarrier for effective glioma treatment.
Peng Y; Huang J; Xiao H; Wu T; Shuai X
Int J Nanomedicine; 2018; 13():3467-3480. PubMed ID: 29942129
[TBL] [Abstract][Full Text] [Related]
6. Delivery of siRNA based on engineered exosomes for glioblastoma therapy by targeting STAT3.
Liang SF; Zuo FF; Yin BC; Ye BC
Biomater Sci; 2022 Mar; 10(6):1582-1590. PubMed ID: 35179533
[TBL] [Abstract][Full Text] [Related]
7. Cation-free siRNA-cored nanocapsules for tumor-targeted RNAi therapy.
Huang X; Li J; Li G; Ni B; Liang Z; Chen H; Xu C; Zhou J; Huang J; Deng S
Acta Biomater; 2023 Apr; 161():226-237. PubMed ID: 36898473
[TBL] [Abstract][Full Text] [Related]
8. cRGD peptide-installed epirubicin-loaded polymeric micelles for effective targeted therapy against brain tumors.
Quader S; Liu X; Chen Y; Mi P; Chida T; Ishii T; Miura Y; Nishiyama N; Cabral H; Kataoka K
J Control Release; 2017 Jul; 258():56-66. PubMed ID: 28483513
[TBL] [Abstract][Full Text] [Related]
9. Bioengineering fluorescent virus-like particle/RNAi nanocomplexes act synergistically with temozolomide to eradicate brain tumors.
Pang HH; Huang CY; Chou YW; Lin CJ; Zhou ZL; Shiue YL; Wei KC; Yang HW
Nanoscale; 2019 Apr; 11(17):8102-8109. PubMed ID: 30982841
[TBL] [Abstract][Full Text] [Related]
10. Amphetamine decorated cationic lipid nanoparticles cross the blood-brain barrier: therapeutic promise for combating glioblastoma.
Saha S; Yakati V; Shankar G; Jaggarapu MMCS; Moku G; Madhusudana K; Banerjee R; Ramkrishna S; Srinivas R; Chaudhuri A
J Mater Chem B; 2020 May; 8(19):4318-4330. PubMed ID: 32330214
[TBL] [Abstract][Full Text] [Related]
11. pH-responsive polymeric micelle carriers for siRNA drugs.
Convertine AJ; Diab C; Prieve M; Paschal A; Hoffman AS; Johnson PH; Stayton PS
Biomacromolecules; 2010 Nov; 11(11):2904-11. PubMed ID: 20886830
[TBL] [Abstract][Full Text] [Related]
12. Self-assembled biodegradable micellar nanoparticles of amphiphilic and cationic block copolymer for siRNA delivery.
Sun TM; Du JZ; Yan LF; Mao HQ; Wang J
Biomaterials; 2008 Nov; 29(32):4348-55. PubMed ID: 18715636
[TBL] [Abstract][Full Text] [Related]
13. Microneedle Patch Delivery of PLCG1-siRNA Efficient Enhanced Temozolomide Therapy for Glioblastoma.
Yang Z; Liu Y; Li H; Tang Q; Yang B; Shi Z; Mao Y
Biomacromolecules; 2024 Feb; 25(2):655-665. PubMed ID: 38242535
[TBL] [Abstract][Full Text] [Related]
14. Co-delivery of siRNA and paclitaxel into cancer cells by biodegradable cationic micelles based on PDMAEMA-PCL-PDMAEMA triblock copolymers.
Zhu C; Jung S; Luo S; Meng F; Zhu X; Park TG; Zhong Z
Biomaterials; 2010 Mar; 31(8):2408-16. PubMed ID: 19963269
[TBL] [Abstract][Full Text] [Related]
15. Nucleolin-Targeting AS1411-Aptamer-Modified Graft Polymeric Micelle with Dual pH/Redox Sensitivity Designed To Enhance Tumor Therapy through the Codelivery of Doxorubicin/TLR4 siRNA and Suppression of Invasion.
Yang S; Ren Z; Chen M; Wang Y; You B; Chen W; Qu C; Liu Y; Zhang X
Mol Pharm; 2018 Jan; 15(1):314-325. PubMed ID: 29250957
[TBL] [Abstract][Full Text] [Related]
16. Biomimetic hypoxia-triggered RNAi nanomedicine for synergistically mediating chemo/radiotherapy of glioblastoma.
Wang Z; Tang XL; Zhao MJ; Zhang YD; Xiao Y; Liu YY; Qian CF; Xie YD; Liu Y; Zou YJ; Yang K; Liu HY
J Nanobiotechnology; 2023 Jul; 21(1):210. PubMed ID: 37408007
[TBL] [Abstract][Full Text] [Related]
17. Brain Co-Delivery of Temozolomide and Cisplatin for Combinatorial Glioblastoma Chemotherapy.
Zou Y; Wang Y; Xu S; Liu Y; Yin J; Lovejoy DB; Zheng M; Liang XJ; Park JB; Efremov YM; Ulasov I; Shi B
Adv Mater; 2022 Aug; 34(33):e2203958. PubMed ID: 35738390
[TBL] [Abstract][Full Text] [Related]
18. Preparation of Polyion Complex Micelles Using Block Copolymers for SiRNA Delivery.
Kim HJ; Zheng M; Miyata K; Kataoka K
Methods Mol Biol; 2016; 1364():89-103. PubMed ID: 26472445
[TBL] [Abstract][Full Text] [Related]
19. Structural modifications in polymeric micelles to impart multifunctionality for improved drug delivery.
Mittal A; Chitkara D
Ther Deliv; 2016; 7(2):73-87. PubMed ID: 26769002
[TBL] [Abstract][Full Text] [Related]
20. A nanoparticle carrying the p53 gene targets tumors including cancer stem cells, sensitizes glioblastoma to chemotherapy and improves survival.
Kim SS; Rait A; Kim E; Pirollo KF; Nishida M; Farkas N; Dagata JA; Chang EH
ACS Nano; 2014 Jun; 8(6):5494-514. PubMed ID: 24811110
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
